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Summary: Theophylline concentrations were determined by fluorescence polarization immunoassay (FPIA)
in saliva, serum and serum water of healthy volunteers and outpatients after administration of single
, theophylline doses, and after the administration of several doses in order to establish a steady state. The
! FPIA allowed rapid and reliable theophylline determinations in saliva and serum water (between-days
j coefficients of Variation: < 3%; recovery: 95 — 103%). Salivary theophylline concentrations measured by
l, ' FPIA in 30 samples agreed well with those determined by HPLC. Furthermore the results obtained by
j ultrafiltration for the concentration of unbound theophylline in serum water were in good agreement with
those determined by ultracentrifugation. The binding of theophylline by serum protein rose by about 25%,
when the pH of the samples was increased from 7.0 to 8.0. After adjusting the pH to 7.4, average values for
l theophylline binding to proteins at 25 °C ranged from 48.5 to 52.2% in serum samples from outpatients and
healthy adults. Salivary theophylline concentrations correlated well with total and free serum theophylline
concentrations in healthy adults and outpatients (r = 0.90—0.98). The theophylline concentration in saliva
was on average about 20—30% higher than the unbound theophylline concentration in serum water. The
l saliva/serum concentration ratio of theophylline showed some intersubject Variation (0.68 ± 0.08; ränge:
0.50—0.85). Using the inean saliva/serum concentration ratio of the patient group, steady state serum
. theophylline concentrations were predicted from salivary levels with a mean error of 7.6% (ränge:
0.0—26.8%). The salivary theophylline concentration appears to be a suitable parameter for assessment of
compliance, for identification of patients with inappropriate dosage, and for consequent dosage adjustment.
1
 Individual dosage optimisation, however, should be based on theophylline concentrations determined in
serum.
ll
i Bestimmung von Theophyllin im Speichel mittels Fluoreszenz-Polarisations-Immunoassay (FPIA)i
\ Zusammenfassung: Die Theophyllin-Konzentration in Speichel, Serum und Serum-Wasser von gesunden
Probanden und ambulanten Patienten wurde nach Verabreichung von Theophyllin-Einzeldosen und im
l steady-state mittels Fluoreszenz-Polarisations-Immunoassay (FPIA) bestimmt. Der FPIA gestattete rasche
und zuverlässige Bestimmungen von Theophyllin im Speichel und Serum-Wasser (Variationskoeffizienten von
Tag zu Tag: < 3%; Wiederfindung: 95-103%). Die mit dem FPIA in 30 Proben gemessenen Theophyllin-
Konzentrationen im Speichel stimhiten gut mit den entsprechenden Resultaten der HPLC überein. Weiterhin
l ergab sich eine gute Übereinstimmung der mittels Ultrafiltration und Ultrazentrifugation bei der Bestimmung
i von ungebundenem Theophyllin im Serum-Wasser erhaltenen Ergebnisse. Bei einem Anstieg des pH der
Probe von 7,0 auf 8,0 wurde eine Zunahme der Bindung von Theophyllin an Serumproteine um 25%
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beobachtet. Nach Einstellung des pH auf 7,4 lagen die mit Serumproben von ambulanten Patienten und
gesunden Erwachsenen gefundenen Mittelwerte für die Proteinbindung von Theophyllin bei 25 °C zwischen
48,5 und 52,2%. Die Theophyllin-Konzentration im Speichel korrelierte bei gesunden Erwachsenen und
ambulanten Patienten gut mit der freien und der Gesamt-Theophyllin-Konzentration im Serum (r =
0,90-0,98). Die Theophyllin-Konzentration im Speichel lag im Mittel etwa 20-30% höher als die freie
Theophyllin-Konzentration im Serum-Wasser. Das Speichel/Serum-KonzentrationsvefhäJtnis von Theophyl-
lin zeigte eine gewisse interindividuelle Variabilität (0,68 + 0,08; Spannweite: 0,50-0,85). Unter Verwendung
des durchschnittlichen Speichel/Serum-Quotienten der Patientengruppe ließen sich die steady-state-Theophyl-
lin-Konzentrationen im Serum anhand der entsprechenden Konzentrationen im Speichel mit einem Fehler
von 7,6% (Spannweite: 0,0—26,8%) vorhersagen. Die Theophyllin-Konzentration im Speichel erscheint als
Kenngröße zur Abschätzung der Patienten-Compliance, zur Erkennung von Patienten mit inadäquater
Dosierung und zur nachfolgenden Dosisadaptation geeignet. Die individuelle Optimierung der Dosierung
sollte jedoch anhand der im Serum bestimmten Theophyllin-Konzentration vorgenommen werden.
Introduction
The monitoring of theophylline serum concentrations
is well established (1). However, conflicting results
have been reported in the literature regarding the
suitability of salivary theophylline concentrations for
monitoring theophylline therapy (2—7). A non-inva-
sive method for monitoring theophylline levels could
play an important role, particularly in the treatment
of nocturnal asthma, where circadian variations of
airway function have to be taken into account (8).
Saliva specimens can be collected by the patient at
any preset time during the interval between doses
outside the clinic. This enables the physician to esti-
mate the actual serum theophylline level from salivary
theophylline concentrations at the time when
asthmatic attacks or toxic Symptoms occur.
In the present study we re-evaluated the question of
whether the salivary theophylline concentration is a
suitable parameter for monitoring theophylline ther-
apy. We therefore compared salivary theophylline
concentrations with free and total serum theophylline
concentrations determined in samples from out-
patients and healthy volunteers receiving the drug.
In addition we investigated the suitability of fluores-
cence polarization immunoassay (FPIA) for rapid
and reliable determinations of salivary and unbound
serum theophylline concentrations.
Materials and Methods
Origin of specimens
Serum and saliva specimens (n = 80) were obtained from 10
healthy volunteers, after administration of a single dose of
theophylline ethylenediamine solution (Euphyllin®, 5.6 mg/kg
anhydrous theophylline) orally or intravenously over a period
of 15 min. One week later the same volunteers received a single
dose of choline theophyllinate tablets (Euspirax®, 6.0 ± 0.6
mg/kg anhydrous theophylline). Venous blood and mixed stirm>
lated saliva was taken 0.5, l, 2, 3, 5, 7, 9 and 12 h after drug
administration.
Furthermore, serum and saliva specimens (n = 56) were ob-
tained at steady state from 8 healthy volunteers whö had
received choline theophyllinate tablets (Euspirax®, 5.7 ± 0.7
mg/kg anhydrous theophylline) at 8.00 a. m. and 8.00 p. m. for
three days. Blood and saliva specimens were taken 0, 2, 4, 6,
8, 10 and 12h after the last administration of the tablets.
Additional serum arid saliva specimens (n = 30) were obtained
from 30 outpatients at steady state. In addition to theophylline,
some of these patients received ß2 sympathomimetics. In eöri-
trast to the volunteers the patients were not instructed to
abstain from methylxanthine-containing beverages and choco-
late.
Collection of saliva specimens
Mixed saliva specimens (2—3ml) were obtained during each
blood sampling in small polystyrol tubes (Sarstedt, Rom-
melsdorf, FRGj. Salivation was stimulated by chewing a piece
of Parafilm® (American Can Comp., Greenwich, U. S. A.) for
about 3 minutes. There was no noticeable adsorption of
theophylline to the polystyrol tubes and Parafilm® used. Sal-
ivary pH was measured using a digital pH meter. The mean
pH value of all stimulated saliva specimens of the outpatients
and volunteers was 6.6 ± 0/6 (ränge: 5.7-7.7). Saliva was
centrifuged at 7000 g for 3 minutes to separate mucus and
cell debris. The süpernatant was used for the theophylline
determination.
Separation of unbound theophylline
The serum samples (n = 246) were kept frozen for .about one
week. Before analysis the pH qf the samples had to be adjüsted
to pH 7.4 with microliter quantities of 1.0 mol/1 HC1, äs the
pH of the samples increased during storage to values between
7.7 and 8.0. For Separation of unbound theophylline ultrafiltra-
tion devices (Centrifree Micropartition System* Amicon Corp.,
Danvers, U.S.A.) were filled with l ml of each serum sample
and centrifuged at 2000 g for 10 minutes (temperature, 25 °C).
The ultrafiltrates were collected and used for tue determination
of unbound theophylline. The absence jof protein from each
ultrafiltrate was checked by using a dip kick (Albustix, Ames*
Elkhart, U. S. A.). In addition, unbound theophylline concen-
trations were determined in the 105 000 g süpernatant of these
serum samples (n = 32) obtained by ultracentrifugation äs
previously described (9).
Determination of binding of theophyll ine to serum
protein at different pH values
The pH of human pool serum was vafied from 7.0 to 8.0. The
samples were adjüsted to the respective pH with 1.0 rnpl/l HC1
or NaOH. The dilution of the serum samples due tp titration
was less than 1%. Unbound theopjhylline was separated by
ultrafiltration äs described above. ; $
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Fluorescence polarization immunoassay (FPIA)
Theophylline determinations in serum, saliva and serum water
were carried out by FPIA (Theophylline Reagent Pack, Abbott
Laboratories, North Chicago, U. S. A.) using the TDx®
Fluorescence Polarization Immunoassay System according to
the instructions of the manufacturer.
High performance l iquid chromatography (HPLC)
Theophylline concentrations in saliva specimens (n = 30) from
volunteers and outpatients were measured by an HPLC method
s described elsewhere (10, 11).
Stat is t ical analysis
The statistical evaluation of the results was based on the stan-
dardised principal component analysis (12) and the significance
of the bias χ - y (paired t-test). Unless stated otherwise mean
values with Standard deviation are given.
Accuracy of FPIA
Average recoveries of theophylline added to drug-
free saliva and to the 105000 g supernatant of drug-
free human serum are shown in table 2. At theophyl-
line concentrations in saliva or serum water between
2.0 and 10.0 mg/1 the recovery ranged, with FPIA,
from 95 to 103%.
Furthermore the results obtained by FPIA with 30
saliva samples from outpatients and volunteers
agreed very well with those determined by HPLC
(fig. 1). The mean value from FPIA was about 6%
higher than that observed with HPLC. Although this
difference was statistically significant (p < 0.05) it
does not seem to be clinically relevant.
Results
Precision of FPIA
At theophylline concentrations in saliva between 7.9
and 10.9 mg/1 and in serum water between 5.3 and
10.1 mg/1 the between-days coefficients of Variation
of single determinations ranged from 1.9—2.5%
(tab. 1).
Tab. 1. Between-days precision of FPIA for the determination
of theophylline in saliva and ultrafiltrate.
Theophylline in saliva3)
x(mg/l) CV(%)C) nd)
Theophylline in ultra-
filtrateb)
χ (mg/1) CV %c) nd)
7.9
10.9
1.9
2.5
14
14
5.3
10.1
2.1
2.2
10
10
a) saliva samples from two outpatients receiving theophylline
b) serum samples from two outpatients receiving theophylline
c) mean value (x) with coefficient of Variation (CV)
d) number of days
Tab. 2. The recovery of theophylline by FPIA in saiiva and
serum water.
Saliva
Theo-
phyl-
line
weighed
in
(mg/0
10
6
4
2
Found1)
(mg/1)
9.7
6.2
4.1
1.8
RecoVr
ery')
(%)
97
103
102
95
n2)
4
4
4
4
Serum water
Theo-
phylr
line
weighed
m
(mg/I)
10
6
4
2
Found
(mg/1)
9.8
6.2
3.8
1.9
Recov-
ery
(%)
98
103
97
95
n
4
4
4
4
') mean value
2) number of contributing values
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Fig. 1. Salivary theophylline concentrations s measured by
HPLC and FPIA in samples from patients and vol-
unteers (n = 30) receiving the drug.
[y = l,02x + 0.26 mg/l; r = 0.98; χ (s) = 6.7 (2.4) mg/l;
y (s) = 7.1 (2.4) mg/1].
Comparison of U l t r a f i l t r a t i o n and ultra-
centr i fugat ion for Separat ion of unbound
theophyl l ine
A comparison was made of the results obtained by
Ultrafiltration and ultracentrifugation for the con-
centration of unbound theophylline in 32 serum
samples from volunteers taking this drug. The results
determined by both methods agreed very well (fig.
2). The mean values found were almost identical (p >
0.05).
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Fig. 2. Serum unbound theophylline concentration determined
by FPIA in 105000g supernatant and ultrafiltrate of
samplös* (n = 32) from volunteers taking the drug.
[y = 1.04x - 0.24 mg/1; r = 0.98; (s) = 5.7 (2.1)
mg/1; y = 5.7 (2.2) mg/1].
Effect of pH on binding of theophyl l ine by
serum protein
Binding of theophylline to serum proteins was found
to be pH-dependent (flg. 3). The percentage of
unbound theophylline decreased from about 60% at
pH 7.0 to 35% at pH 8.0 in samples of human
pool serum. The average values for the percentage of
theophylline bound to serum proteins in samples
from 10 healthy volunteers and 30 outpatients were
49.9 ± 3.1% and 48.5 ± 4.9%, respectively
(temperature: 25 °C; pH: 7.4).
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c
D
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pH
Fig. 3. Effect of pH on theophylline binding to serum proteins.
Each point represents the average valüe of de-
terminations on two samples of human pool serum,
Comparison of theophylline concen-
trations in saliva, serum and serum water
Averaged concentration-time curves of theophylline
in saliva, serum and ultrafiltrate for 10 healthy vol-
unteers after administration of a single dose of a
theophylline ethylenediamine sölution are shown in
figüre 4. The mean theophylline cöhceiitration in
saliva was 20.2% higher than that in ultrafiltrate.
This difference was statistically significänt (p < 0.05).
The averaged concentration-time curves of theophyl-
line in saliva, serum and ultrafil träte for 10 healthy
volunteers after administration of a single dose of
choline theophyllinate tablets are shöwü in figüre 5.
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Fig. 4. Averaged concentration-time curves of theophylline in
serum (A — ), saliva (6—6) and ultiafütrate (H—B)
after administration of a single dose of a theophylline
ethylenediamine solütion (5.6 mg/kg amiydrous
theophylline) in healthy volunteers (n = 10). Verticai
bars represent Standard deviation.
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Fig. 5. Averaged concentration-time curves of theophylline in
serum (A —A), saliva (·-·) and ultrafiltrate (·-·)
after administration of a single dose of choline
theophyllinate tablets (6:0 ± 0.6 mg/kg anhydrous
theophylline) in healthy volunteers (h = 10). Verticai
bars represent Standard deviation.
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The mean theophylline concentration in saliva was
significantly 29.0% higher than that in ultrafiltrate
(p < 0.05). Figure 6 shows the averaged con-
centration-time curves of theophylline in saliva,
serum and ultrafiltrate for 8 healthy volunteers who
received choline theophyllinate tablets for 3 days.
The mean value of the theophylline concentrations
in saliva was 19.2% higher than that in ultrafiltrate
(p < 0.05).
Between 0.5 and 12h after the administration of
a single dose of the theophylline ethylenediamine
solution or choline theophyllinate tablets, the saliva/
serum ratios of the 10 volunteers decreased sig-
nificantly from an average 0.63 to 0.55 and 0.73 to
0.60, respectively (tab. 3). The corresponding saliva/
serum water concentration ratios of these subjects
showed a statistically significant decrease from an
average 1.29 to 1.05 and 1.39 to 1.11, respectively
(tab. 3). However, at steady state the theophylline
saliva/serum concentration ratios of theophylline
determined between 0 to 12 h after administration of
choline theophyllinate tablets did not show a sig-
nificant difference (p > 0.05) (tab. 4). The saliva/
serum water concentration ratio of theophylline in-
creased significantly from an average 1.09 to 1.31 (p
< 0.05).
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Fig. 6. Averaged concentration-time curves of theophylline in
serum (A — A ) , saliva (o —o) and ultrafiltrate (a —D)
at steady state after the administration of choline the-
ophyllinate tablets at 8.00 a. m. and 8.00 p. m. for
three days (5.7 ± 0.7 mg/kg anhydrous theophylline)
in healthy volunteers (n = 8). Vertical bars represent
Standard deviation.
[theophylline bound to serum proteins: χ (s) = 52.2
(4.3)%].
Tab. 3. The mean saliva/serum and saliva/serum water concentration ratio of theophylline with Standard deviation in healthy
volunteers (n = 10) 0.5 to 12h after administration of a single dose of theophylline ethylenediamine solution (A) and
choline theophyllinate tablets (B).
A
B
a)
b)
a)
b)
a)
b)
0,5
0.63
(0.14)
1.29
(0.14)
0.73
(0.12)
1.39
(0.09)
1
0.59
(0.08)
1.27
(0.18)
0.68
(0.15)
1.36
(0.18)
2
0.58
(0.09)
1.26
(0.12)
0.65
(0.11)
1.36
(0.17)
3
0.58
(0.09)
1.24
(0.14)
0.63
(0.08)
1.28
(0.09)
5
0.57
(0.08)
1.18
(0.10)
0.60
(0.07)
1.34
(0.16)
7
0.55
(0.09)
1.18
(0.09)
0.60
(0.07)
1.24
(0.16)
9
0.55
(0.07)
1.13
(0.09)
0.60
(0.05)
1.22
(0.09)
12
0.55
(0.07)
1.05
(0.09)
0.60
(0.05)
1.11
(0.14)
h
saliva/serum concentration ratio of theophylline
saliva/serum water concentration ratio of theophylline
Tab. 4. The mean
volunteers
a)
b)
0
0.50
(0,07)
1.09
(0.15)
saliva/serum and sajiva/serum water concentration ratio of theophylline with Standard
(n = 8) 0 to 12 h after administration of choline theophyllinate tablets for 3 days.
2
0.50
(0.06)
1.18
(0.12)
4
0.51
(0.08)
1.16
(0.13)
6
0.52
(0.07)
1.17
(0.11)
8
0.51
(0.07)
1.20
(0.13)
10
0.54
(0.09)
1.24
(0.15)
deviation in
12
0.53
(0.08)
1.31
(0.14)
healthy
h
a) saliva/serum concentration ratio of theophylline
b) saliva/serum water concentration ratio of theophylline
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In figure 7 serum theophylline concentrations ob-
tained in samples from 30 outpatients are compared
with the corresponding salivary theophylline concen-
trations. A high correlation was found (r = 0.97).
The mean saliva/serum concentration ratio of the-
ophylline was 0.68 ± 0.08 (r nge: 0.50-0.85). The
serum theophylline concentrations of the 30 out-
patients ranged from l .6 to 17.3 mg/1, and the salivary
concentrations from 0.7 to 9.5 mg/1. The serum water
theophylline concentrations obtained in samples from
these outpatients correlated well with the correspond-
ing salivary theophylline concentrations s shown in
figure 8 (r = 0.98). The mean saliva/serum water
concentration ratio of theophylline was 1.34 ± 0.11
(r nge: 1.17-1.60).
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Fig. 7. Comparison of salivary theophylline concentrations
with the corresponding serum theophylline con-
centrations in samples from outpatients (n = 30) treated
with the drug.
[y = 0.68x -h 0.01 mg/1; r = 0.97; χ (s) = 10.5 (4.3)
mg/1; y (s) = 7.1 (2.9) mg/1].
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Fig. 8. Comparison of salivary theophylline concentrations
with the corresponding serum water theophylline con-
centrations in samples from outpatients (n = 30) treated
with the drug.
[y = 1.28x + 0.28 mg/1; r = 0.98; χ (s) = 5.4 (2.3) mg/1;
y(s)-7.1(2.9)mg/l].
Table 5 shows a comparison of predicted serum
theophylline levels with the observed serum theophyl-
line concentrations. The prediction is based on a
mean saliva/serum concentration ratio of 0.68
obtained in 30 outpatients; A mean absolute pre-
diction error of 7.6% (r nge: 0.0-26.8%) was found.
Tab. 5. Comparison between predicted (Css pred) and measured (Css m) steady state seruna theophylline concentrations. In each
patient serum theophylline concentrations were predicted from the corresponding salivary levels using a mean group
saliva/serum concentration ratio of 0.68.
Patient
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
M %r>p
Css pred
(mg/1)
17.3
7.5
15.3
5.1
9.8
12.9
10.1
9.1
9.8
12.0
12.3
9.4
16.2
15.6
12.9
Css pred
v —
Css m
(mg/1)
16.2
7.8
14.7
4.5
10.7
12.7
8.1
8.6
8.1
11.2
12.4
9.1
17.3
16.7
12.8
-
Cssm
.mn
% Dev.1)
+ 6.8
- 3.9
. Φ 4.1
+ 13.3
- 8.4
-h 1.6
+24.7
+ 5.8
+ 21.0
+ 7.1
- 0.8
+ 3.3
- 6.4
- 6.6
+ 0.8
2) mean absolute
Patient
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
*«
% deviation
Css pred
(mg/1)
14.4
11.3
2.5
12.3
2.3
12.8
- 8.1
7.2
1.3
12.3
4.1
16.2
9.6
10.6
13.4
10.5 + 4.3
Css m
(mg/1) .
14.9
12.2
2.5
12.0
1.9
12.3
9.0
7.2
1.6
12.1
5.6
16.1
10.2 ·
11.2
14.0
10.5 ± 4.3
;
% Dev.1)
- 3.4
- 7.4
0.0
+ 2.5
' +21.1
+ 4.1
-10.0
0.0
-18.8
+ 1.7
-26.8
+ 0.6
- 5.9
- 5.4
- 4.3
7.62)
Css m
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Discussion
The results of our study indicate that FPIA is very
well suited for rapid and reliable theophylline de-
terminations in saliva and serum water. Nineteen
different samples from patients can be analysed by
this method in about 10 minutes. Regarding the Sep-
aration of unbound theophylline, the results obtained
with the Ultrafiltration technique agreed well with
those using ultracentrifugation.
In order to obtain meaningful data on the unbound
fraction of theophylline it is necessary to carefully
control the pH value of the serum samples. In agree-
ment with various other authors (13 — 15) we
observed a distinct dependence of serum protein bind-
ing of theophylline upon serum pH (fig. 3). At a
serum pH of 7.4 and a temperature of 25 °C we
found a mean serum protein binding of about 50%.
Somewhat higher values for the protein binding of
theophylline have been observed in previous studies,
in which the pH of samples was apparently not con-
trolled (16). Since the pH increases in stored serum
samples due to CÜ2 release, falsely elevated values
for the binding of theophylline to serum protein are
obtained, if the pH of the sample is not adjusted to
7.4(13).
In our study high overall correlation coefficients were
found between salivary and serum theophylline levels
(r = 0.90) and between salivary and unbound serum
theophylline concentrations (r = 0.91) in healthy
volunteers after administration of single theophylline
doses and at steady state. During the first few hours
after intravenous ör oral administration of single
theophylline doses, saliva/serum ratios were sig-
nificantly higher arid mofe variable than at the end
of the experimental period of 12 hours (tab. 3). This
phenomenon has also been described by Koysooko et
al. (7) and Uden et al. (17). The possibility cannot be
excluded that this finding is due to an active secretion
of theophylline into saliva during the initial period
(18). At steady state, however, no significant changes
of the saliva/serum concentration ratio were observed
during a 12 hpur period between doses .(tab. 4). So
far, no explanation is available for the significant
increase of the saliva/serum water concentration ratio
at steady state (tab. 4). In samples from healthy
volunteers and outpatients the theophylline con-
centration in saliva was, on average, about 20 — 30%
higher than the unbound theophylline concentration
in serum water. This finding is consistent with those
of other aüthors (19). The coneentration of theophyl-
line in saliva is reportedly neither influenced by sal-
ivary pH nor flow rates (4, 5, 18, 20, 21). Moreover,
only very little theophylline seems to be bound to
salivary proteins (22).
A high correlation was found between salivary and
serum äs well äs salivary and serum water theophyl-
line concentrations in 30 outpatients treated with this
drug (figs. 7, 8). The saliva/serum concentration ratio
of theophylline determined in this study is consistent
with those reported by various other authors (2, 3,
4, 6, 23). During a test period of 12 hours no relevant
intrasubject change of this ratio was detected (tabs.
3, 4). Data from the literature (2, 7) also indicate that
in general there is only slight intrasubject variability
of this ratio from week to week. However, in agree-
ment with various other investigators (3, 6, 17, 23),
some intersubject Variation of the saliva/serum con-
centration ratio of theophylline was found (ränge:
0.50 — 0.85). Using the average saliva/serum con-
centration ratio of theophylline obtained with
samples from these patients, predicted serum
theophylline levels were compared with the observed
measured values (tab. 5). A mean absolute deviation
of 7.6% between predicted and measured serum
theophylline concentrations was found. The observed
deviations fanged from 0—27% with only 4 patients
out of 30 showing a prediction error between 20 and
27%. However, serum theophylline levels predicted
from salivary theophylline concentrations should be
interpreted carefully, if the individual saliva/serum
ratio of a patient is not known. The wide inter-
laboratory Variation in saliva/serum concentration
ratios is at least partly due to different methods of
saliva collection. Standardised Stimulation of sal-
ivation äs described in this study might also help to
reduce intralaboratory Variation of this ratio.
From the results of our study we conclude that the
theophylline concentration in stimulated saliva is a
clinically valuable parameter for monitoring
theophylline therapy. When interpreting salivary
theophylline levels, however, the intersubject vari-
ability of the saliva/serum concentration ratio of this
substance should be taken into account. Salivary
theophylline concentrations are useful for the as-
sessment of compliance and the identification of
patients who receive inadequate or excessive
theophylline do'ses. This non-invasive method is of
particular interest for the large number of outpatients
with nocturnal or unstable asthma, äs it allows
theophylline determinations at any time during the
dosing interval. Monitoring of salivary theophylline
concentrations could identify the role of theophylline
in the overall drug regimen especially before embark-
ing on steroid treatment. The individual dosage
optimisation and the verification of suspected
overdosage, however, should always be based on
theophylline concentrations determined in serum.
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